Metraipolis › archive › dc_a4d32ca69394

Concentrated micro choice-based treatment for type 2 diabetes is associated with decreased risk of sleep apnoea, less daytime sleepiness and lower insomnia… — Europe PMC PMID:41425203

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41425203
DOI
10.3389/frsle.2025.1639626
License (as archived)
solo-consultazione
Archived
2026-11-09T23:07:54.589Z
SHA-256 of the archived text
457f4c0f425df90dae349367575435bd12fed56d9f3fb554f67eabacd7621bf6
Stable URL of this page
https://metraipolis.com/documento/dc_a4d32ca69394

How to cite

Concentrated micro choice-based treatment for type 2 diabetes is associated with decreased risk of sleep apnoea, less daytime sleepiness and lower insomnia… — Europe PMC PMID:41425203 — Europe PMC (en), https://europepmc.org/article/MED/41425203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a4d32ca69394 (Metraipolis archive dc_a4d32ca69394, sha256 457f4c0f425df90dae349367575435bd12fed56d9f3fb554f67eabacd7621bf6)
BibTeX
@misc{dca4d32ca69394,
  title = {Concentrated micro choice-based treatment for type 2 diabetes is associated with decreased risk of sleep apnoea, less daytime sleepiness and lower insomnia… — Europe PMC PMID:41425203},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41425203},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a4d32ca69394; sha256 457f4c0f425df90dae349367575435bd12fed56d9f3fb554f67eabacd7621bf6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41425203. Agents can read the archived copy with the MCP tool read_document.